Adult Intraventricular Hemorrhage Market

DelveInsight’s ‘Adult Intraventricular Haemorrhage Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of Adult Intraventricular Hemorrhage and the historical and forecasted Adult Intraventricular Hemorrhage market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.


The Adult Intraventricular Haemorrhage market report provides an overview of Adult Intraventricular Hemorrhage, applications of Adult Intraventricular Hemorrhage as well as its PEST Analysis. Additionally, the report provides insight on the Adult Intraventricular Hemorrhage market share of the individual Adult Intraventricular Hemorrhage, current and forecasted Adult Intraventricular Hemorrhage market size from 2018 to 2026, segmented by seven major markets. The report also covers the market drivers, market barriers and unmet needs to curate the best of opportunities and assesses underlying potential of the market.

Adult Intraventricular Haemorrhage Overview

Intraventricular hemorrhage (IVH) in adults usually occurs in the setting of aneurysmal subarachnoid hemorrhage or hypertension-related intracerebral hemorrhage. It is bleeding inside or around the ventricles in the brain. The ventricles are the spaces in the brain that contain the cerebral spinal fluid. Bleeding in the brain can put pressure on the nerve cells and damage them. Severe damage to cells can lead to brain injury.


In adults, the symptoms are similar to intracerebral hemorrhages and include sudden onset of headache, nausea and vomiting, together with an alteration of the mental state and/or level of consciousness. Prognosis is very poor when IVH results from intracerebral hemorrhage related to high blood pressure and is even worse when Adult Intraventricular Hemorrhage follows.


The treatment is focused on monitoring and managing IVH by the multiple pharmacologic, surgical, and critical care interventions directed toward the diagnosis and treatment of the underlying cause of IVH. The most immediate threat to life posed by IVH is the development of acute obstructive Adult Intraventricular Hemorrhage and must be treated emergently with external ventricular drainage (EVD) through an intraventricular catheter (IVC).


Study Period: 2018–2026

Geography Covered

  • The US
  • EU5 (Germany, France, Spain, Italy, and the United Kingdom)
  • Japan

List of Companies:

  • IRRAS,Medtronic plc
  • Integra LifeSciences Corporation
  • Codman & Shurtleff, Inc.
  • RAUMEDIC AG
  • Vittamed
  • Sophysa Ltd.
  • Orsan Medical Technologies
  • Spiegelberg GmbH & Co. KG
  • Sophysa SA, Vivonics Inc.
  • Neural Analytics
  • Natus Medical Incorporated

Adult Intraventricular Haemorrhage- Competitive Analysis

This segment of the report provides a brief competitive analysis of Adult Intraventricular Hemorrhage, to help understand the competition in the market. It gives a comparative understanding of the products based on types.

Adult Intraventricular Haemorrhage: Market Segmentation

By Device Type

  • External Ventricular Drainage,
  • Intracranial Pressure Monitoring Devices
  • Combination Systems


By End User

  • Hospitals
  • Trauma Centers

Adult Intraventricular Haemorrhage: Market Dynamics

Market Drivers

  • The rising incidence of strokes.
  • The increase demand for minimally invasive surgeries.


Market Barriers

  • Complications associated with the surgery.
  • Stringent regulatory product approval process.

Adult Intraventricular Haemorrhage: Market Analysis

This segment illustrates the market of Adult Intraventricular Hemorrhage across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Adult Intraventricular Hemorrhage domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Adult Intraventricular Hemorrhage market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Adult Intraventricular Hemorrhage, explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Adult Intraventricular Hemorrhage is provided, which will have an impact on the future market of Adult Intraventricular Hemorrhage.
  • A detailed review of Adult Intraventricular Hemorrhage market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Adult Intraventricular Hemorrhage market.

Report Highlights

  • The report covers descriptive overview of the Adult Intraventricular Hemorrhage, explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Adult Intraventricular Hemorrhage market.
  • The report also reviews the detailed historical and forecasted Adult Intraventricular Hemorrhage market, including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Adult Intraventricular Hemorrhage market.

Adult Intraventricular Haemorrhage Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size

Adult Intraventricular Haemorrhage Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the Adult Intraventricular Hemorrhage market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Adult Intraventricular Hemorrhage total market size as well as market size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across the 7MM and which country will have the largest Adult Intraventricular Hemorrhage market size during the forecast period (2018–2026)?
  • At what CAGR, the Adult Intraventricular Hemorrhage market is expected to grow in the 7MM during the forecast period (2018–2026)?
  • What will be the Adult Intraventricular Hemorrhage market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Adult Intraventricular Hemorrhage market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Adult Intraventricular Hemorrhage market?
  • What are the Adult Intraventricular Hemorrhage available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Adult Intraventricular Hemorrhage?
  • What are the key collaborations (Industry–Industry), mergers and acquisitions, licensing activities related to the Adult Intraventricular Hemorrhage?
  • What are the key designations that have been granted for the current Adult Intraventricular Hemorrhage?
  • What are the 7MM countries historical and forecasted market of Adult Intraventricular Hemorrhage?

Frequently Asked Questions

What is Adult Intraventricular Haemorrhage?

Intraventricular hemorrhage (IVH) in adults usually occurs in the setting of aneurysmal subarachnoid hemorrhage or hypertension-related intracerebral hemorrhage. It is bleeding inside or around the ventricles in the brain.


How is Adult Intraventricular Haemorrhage Market Segmented?

The Adult Intraventricular Haemorrhage is segmented on the basis by Device Type and by End User.


Who are the leading companies in Adult Intraventricular Haemorrhage Market Landscape?

The leading companies that are working in the Adult Intraventricular Haemorrhage Market are IRRAS,Medtronic plc, Integra LifeSciences Corporation, Codman & Shurtleff, Inc., RAUMEDIC AG, Vittamed, Sophysa Ltd., Orsan Medical Technologies, Spiegelberg GmbH & Co. KG, Sophysa SA, Vivonics Inc., Neural Analytics, Natus Medical Incorporated and many others.


What are the Adult Intraventricular Haemorrhage Market Drivers?

The market driver is rising incidence of strokes and the increase demand for minimally invasive surgeries.


What are the Adult Intraventricular Haemorrhage Market Barriers?

The market barrier is complications associated with the surgery and stringent regulatory product approval process.


What are the key strengths of Adult Intraventricular Haemorrhage Market Report?

Key strengths of Adult Intraventricular Haemorrhage Market Report are 6 Years Forecast, 7MM Coverage, Competitive Landscape, PEST Analysis, Market Size, Market Drivers and Market Barriers.


What is the Impact of COVID-19 on Adult Intraventricular Haemorrhage Market?

The Adult Intraventricular Haemorrhage Market had observed a positive shift in market revenues due to the COVID 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1. Key Insights

2. Executive Summary of Adult Intraventricular Hemorrhage

3. Adult Intraventricular Hemorrhage: Background and Overview

3.1. Introduction

3.2. Types of Adult Intraventricular Hemorrhage

3.3. Advantages of Adult Intraventricular Hemorrhage

3.4. Disadvantages of Adult Intraventricular Hemorrhage

4. Adult Intraventricular Hemorrhage: Regulatory Scenario

5. Adult Intraventricular Hemorrhage: Reimbursement Scenario

6. Company Profiles

6.1. Natus Medical Incorporated

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.2.1. Product description

6.1.2.2. Regulatory Milestones

6.1.2.3. Research and Development

6.1.2.4. Product Development Activities

6.2. Integra Lifesciences

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.2.1. Product description

6.2.2.2. Regulatory Milestones

6.2.2.3. Research and Development

6.2.2.4. Product Development Activities

More Companies in the final report…

7. Adult Intraventricular Hemorrhage: Competitive Analysis

8. KOL Views

9. Adult Intraventricular Hemorrhage: Market Analysis in 7MM

9.1. Adult Intraventricular Hemorrhage: Market Analysis in 7MM by Device Type (2018–2026)

9.2. Adult Intraventricular Hemorrhage: Market Analysis in 7MM by End User (2018–2026)

10. Country-Wise Market size of Adult Intraventricular Hemorrhage in 7MM (2018–2026)

10.1. Market size of Adult Intraventricular Hemorrhage in the United States

10.1.1. Adult Intraventricular Hemorrhage: Market Analysis in the United States by Device Type (2018–2026)

10.1.2. Adult Intraventricular Hemorrhage: Market Analysis in the United States by End User (2018–2026)

10.2. Market size of Adult Intraventricular Hemorrhage in Germany

10.2.1. Adult Intraventricular Hemorrhage: Market Analysis in Germany by Device Type (2018–2026)

10.2.2. Adult Intraventricular Hemorrhage: Market Analysis in Germany by End User (2018–2026)

10.3. Market size of Adult Intraventricular Hemorrhage in France

10.3.1. Adult Intraventricular Hemorrhage: Market Analysis in France by Device Type (2018–2026)

10.3.2. Adult Intraventricular Hemorrhage: Market Analysis in France by End User (2018–2026)

10.4. Market size of Adult Intraventricular Hemorrhage in Spain

10.4.1. Adult Intraventricular Hemorrhage: Market Analysis in Spain by Device Type (2018–2026)

10.4.2. Adult Intraventricular Hemorrhage: Market Analysis in Spain by End User (2018–2026)

10.5. Market size of Adult Intraventricular Hemorrhage in Italy

10.5.1. Adult Intraventricular Hemorrhage: Market Analysis in Italy by Device Type (2018–2026)

10.5.2. Adult Intraventricular Hemorrhage: Market Analysis in Italy by End User (2018–2026)

10.6. Market size of Adult Intraventricular Hemorrhage in UK

10.6.1. Adult Intraventricular Hemorrhage: Market Analysis in UK by Device Type (2018–2026)

10.6.2. Adult Intraventricular Hemorrhage: Market Analysis in UK by End User (2018–2026)

10.7. Market size of Adult Intraventricular Hemorrhage in Japan

10.7.1. Adult Intraventricular Hemorrhage: Market Analysis in Japan by Device Type (2018–2026)

10.7.2. Adult Intraventricular Hemorrhage: Market Analysis in Japan by End User (2018–2026)

11. Market Dynamics

11.1. Market Drivers

11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Adult Intraventricular Hemorrhage Market Analysis in the 7MM (2018–2026)

Table 3: Adult Intraventricular Hemorrhage Market Analysis in the 7MM by Device Type (2018–2026)

Table 4: Adult Intraventricular Hemorrhage Market Analysis in the 7MM by End User (2018–2026)

Table 5: Adult Intraventricular Hemorrhage United States Market Analysis (2018–2026)

Table 6: Adult Intraventricular Hemorrhage Market Analysis in the US by Device Type (2018-2026)

Table 7: Adult Intraventricular Hemorrhage Market Analysis in the US by End User (2018-2026)

Table 8: Adult Intraventricular Hemorrhage Germany Market Analysis (2018–2026)

Table 9: Adult Intraventricular Hemorrhage Market Analysis in Germany by Device Type (2018-2026)

Table 10: Adult Intraventricular Hemorrhage Market Analysis in Germany by End User (2018-2026)

Table 11: Adult Intraventricular Hemorrhage France Market Analysis (2018–2026)

Table 12: Adult Intraventricular Hemorrhage Market Analysis in France by Device Type (2018-2026)

Table 13: Adult Intraventricular Hemorrhage Market Analysis in France by End User (2018-2026)

Table 14: Adult Intraventricular Hemorrhage Spain Market Analysis (2018–2026)

Table 15: Adult Intraventricular Hemorrhage Market Analysis in Spain by Device Type (2018-2026)

Table 16: Adult Intraventricular Hemorrhage Market Analysis in Spain by End User (2018-2026)

Table 17: Adult Intraventricular Hemorrhage Italy Market Analysis (2018–2026)

Table 18: Adult Intraventricular Hemorrhage Market Analysis in Italy by Device Type (2018-2026)

Table 19: Adult Intraventricular Hemorrhage Market Analysis in Italy by End User (2018-2026)

Table 20: Adult Intraventricular Hemorrhage United Kingdom Market Analysis (2018–2026)

Table 21: Adult Intraventricular Hemorrhage Market Analysis in the UK by Device Type (2018-2026)

Table 22: Adult Intraventricular Hemorrhage Market Analysis in the UK by End User (2018-2026)

Table 23: Adult Intraventricular Hemorrhage Japan Market Analysis (2018–2026)

Table 24: Adult Intraventricular Hemorrhage Market Analysis in Japan by Device Type (2018-2026)

Table 25: Adult Intraventricular Hemorrhage Market Analysis in Japan by End User (2018-2026)

List of Figures

Figure 1: Product description of Adult Intraventricular Hemorrhage

Figure 2: Adult Intraventricular Hemorrhage Market Analysis in the 7MM (2018–2026)

Figure 3: Adult Intraventricular Hemorrhage Market Analysis in the 7MM by Device Type (2018–2026)

Figure 4: Adult Intraventricular Hemorrhage Market Analysis in the 7MM by End User (2018–2026)

Figure 5: Adult Intraventricular Hemorrhage United States Market Analysis (2018–2026)

Figure 6: Adult Intraventricular Hemorrhage Market Analysis in the US by Device Type (2018-2026)

Figure 7: Adult Intraventricular Hemorrhage Market Analysis in the US by End User (2018-2026)

Figure 8: Adult Intraventricular Hemorrhage Germany Market Analysis (2018–2026)

Figure 9: Adult Intraventricular Hemorrhage Market Analysis in Germany by Device Type (2018-2026)

Figure 10: Adult Intraventricular Hemorrhage Market Analysis in Germany by End User (2018-2026)

Figure 11: Adult Intraventricular Hemorrhage France Market Analysis (2018–2026)

Figure 12: Adult Intraventricular Hemorrhage Market Analysis in France by Device Type (2018-2026)

Figure 13: Adult Intraventricular Hemorrhage Market Analysis in France by End User (2018-2026)

Figure 14: Adult Intraventricular Hemorrhage Italy Market Analysis (2018–2026)

Figure 15: Adult Intraventricular Hemorrhage Market Analysis in Spain by Device Type (2018-2026)

Figure 16: Adult Intraventricular Hemorrhage Market Analysis in Spain by End User (2018-2026)

Figure 17: Adult Intraventricular Hemorrhage Italy Market Analysis (2018–2026)

Figure 18: Adult Intraventricular Hemorrhage Market Analysis in Italy by Device Type (2018-2026)

Figure 19: Adult Intraventricular Hemorrhage Market Analysis in Italy by End User (2018-2026)

Figure 20: Adult Intraventricular Hemorrhage United Kingdom Market Analysis (2018–2026)

Figure 21: Adult Intraventricular Hemorrhage Market Analysis in the UK by Device Type (2018-2026)

Figure 22: Adult Intraventricular Hemorrhage Market Analysis in the UK by End User (2018-2026)

Figure 23: Adult Intraventricular Hemorrhage Japan Market Analysis (2018–2026)

Figure 24: Adult Intraventricular Hemorrhage Market Analysis in Japan by Device Type (2018-2026)

Figure 25: Adult Intraventricular Hemorrhage Market Analysis in Japan by End User (2018-2026)

Figure 26: Market Drivers

Figure 27: Market Barriers

IRRAS,Medtronic plc

Integra LifeSciences Corporation

Codman & Shurtleff, Inc.

RAUMEDIC AG

Vittamed

Sophysa Ltd.

Orsan Medical Technologies

Spiegelberg GmbH & Co. KG

Sophysa SA, Vivonics Inc.

Neural Analytics

Natus Medical Incorporated

  • Tags:
  • Adult Intraventricular Hemorrhage C...
  • Adult Intraventricular Hemorrhage
  • Adult Intraventricular Hemorrhage...
  • Adult Intraventricular Hemorrhage...
  • Adult Intraventricular Hemorrhage...
  • Adult IVH Market Share
  • IVH market share
  • IVH treatment devices

Forward to Friend

Need A Quote